메뉴 건너뛰기




Volumn 67, Issue 1, 2009, Pages 55-65

Evaluation of Variant II® analyzer equipped with the new 270-2101 NU kit (Bio-Rad) for HbA 1c assay;Evaluation de l'analyseur Variant II® équipé de la nouvelle trousse 270-2101 NU (Bio-Rad) pour le dosage de l'HbA 1c

Author keywords

Evaluation; HbA 1c; High pressure liquid chromatography

Indexed keywords

ANTICOAGULANT AGENT; BILIRUBIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN D; HEMOGLOBIN E; HEMOGLOBIN J; HEMOGLOBIN VARIANT;

EID: 60349083849     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2008.0289     Document Type: Article
Times cited : (14)

References (13)
  • 1
    • 0032837603 scopus 로고    scopus 로고
    • 1c : Concertation clinico-biologique pour la standardisation des méthodes de dosage.
    • 1c : Concertation clinico-biologique pour la standardisation des méthodes de dosage. Diabetes Metab 1999 ; 25 : 283-7.
    • (1999) Diabetes Metab , vol.25 , pp. 283-287
    • Gillery, P.1    Bordas-Fonfrède, M.2    Chapelle, J.P.3
  • 2
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complications Trial Research Group
    • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 ; 329 : 977-86.
    • (1993) N Engl J Med , vol.329 , pp. 977-986
  • 3
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 ; 352 : 837-53.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 4
    • 34548792393 scopus 로고    scopus 로고
    • Global standardisation of glycated hemoglobin measurement : The position of the IFCC Working Group
    • Mosca A, Goodall I, Hoshino T, et al. Global standardisation of glycated hemoglobin measurement : the position of the IFCC Working Group. Clin Chem Lab Med 2007 ; 45 : 1077-80.
    • (2007) Clin Chem Lab Med , vol.45 , pp. 1077-1080
    • Mosca, A.1    Goodall, I.2    Hoshino, T.3
  • 10
    • 0001068517 scopus 로고
    • Protocole de validation de techniques.
    • Vassault A, Grafmeyer D, Naudin C, et al. Protocole de validation de techniques. Ann Biol Clin 1986 ; 44 : 686-745.
    • (1986) Ann Biol Clin , vol.44 , pp. 686-745
    • Vassault, A.1    Grafmeyer, D.2    Naudin, C.3
  • 11
    • 22244484994 scopus 로고
    • Protocole d'étude de la contamination dans les analyseurs biochimiques.
    • Naudin C, Vassault A, Truchaud A. Protocole d'étude de la contamination dans les analyseurs biochimiques. Ann Biol Clin 1988 ; 46 : 213-9.
    • (1988) Ann Biol Clin , vol.46 , pp. 213-219
    • Naudin, C.1    Vassault, A.2    Truchaud, A.3
  • 12
    • 84908219488 scopus 로고
    • Statistical methods for assessing agreement between two methods of clinical measurement
    • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 ; 1 : 307-10.
    • (1986) Lancet , vol.1 , pp. 307-310
    • Bland, J.M.1    Altman, D.G.2
  • 13
    • 0033838298 scopus 로고    scopus 로고
    • 1c et hémoglobinopathies : Problèmes posés et conduite à tenir.
    • 1c et hémoglobinopathies : problèmes posés et conduite à tenir. Ann Biol Clin 2000 ; 58 : 425-30.
    • (2000) Ann Biol Clin , vol.58 , pp. 425-430
    • Gillery, P.1    Hue, G.2    Bordas-Fonfrède, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.